You are here

Vaccines

Primary tabs

Information on vaccines to counter Ebola and other diseases

The Mission of this group is to follow the development of vaccines and other medications to counter Ebola and other diseases.

Members

Kathy Gilbeaux mdmcdonald MDMcDonald_me_com mike kraft

Email address for group

vaccines_global@m.resiliencesystem.org

Negative view of COVID vaccines continue - new polls

...

The results of the present study show many Americans still hold a dismissive view of COVID-19 vaccines. As of April 2023, 30% of the population have not been vaccinated with primary doses, and 83% of those eligible have not received a booster dose.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Bivalent COVID-19 booster outperforms monovalent version --new study

A new Italian study finds that estimated relative vaccine effectiveness (rVE) was 49.3% for the bivalent (two-strain) booster and 26.9% for the monovalent (single-strain) booster, with protection lasting at least 4 months for the bivalent booster and waning fast for the monovalent version. The study appears in The Lancet Infectious Diseases.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Indications of a US COVID-19 uptick; more details of new vaccine rollout

Though COVID has held at very low levels late spring and into summer, some early indicators show signs of rising activity, according to the latest data from the Centers for Disease Control and Prevention (CDC).

In other developments, the CDC and the Department of Health and Human Services (HHS) fleshed out more details about when the updated COVID-19 vaccine will roll out and how federal health officials will ensure that uninsured and underinsured people can receive their doses.

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

howdy folks
Page loaded in 1.093 seconds.